Insulin Degludec (U-100) Vials and Ranibizumab Intraocular
Determining the interaction of Insulin Degludec (U-100) Vials and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Degludec (U-100) Vials-Ranibizumab ophthalmic
- Insulin Degludec (U-100) Vials-Ranitidine
- Insulin Degludec (U-100) Vials-Ranitidine Capsule
- Insulin Degludec (U-100) Vials-Ranitidine Hydrochloride
- Insulin Degludec (U-100) Vials-Ranitidine Injection
- Insulin Degludec (U-100) Vials-Ranitidine Suspension
- Ranibizumab Intraocular-Insulin Degludec (U-200) Prefilled Pens
- Ranibizumab Intraocular-Insulin degludec and liraglutide
- Ranibizumab Intraocular-Insulin degludec and liraglutide Subcutaneous
- Ranibizumab Intraocular-Insulin degludec Subcutaneous
- Ranibizumab Intraocular-Insulin detemir
- Ranibizumab Intraocular-Insulin Detemir (Cartridges and Prefilled Syringes)